Japan News
-
Mechanical stress may affect normal bone development
Japan | News | 0 Comment | 21 Jan, 2019
The bone matrix contains various proteins, namely, collagen and other non-collagenous proteins. Osteoblasts are responsi...Read more
-
Thyas signs a licensing agreement with iPS-AJ
Japan | News | 1 Comment | 18 Jan, 2019
Thyas has signed a licensing agreement with iPS Academia Japan, Inc. (iPS-AJ), a technology licensing organization of in...Read more
-
J&J completes acquisition of Ci:z Holdings
Japan | News | 0 Comment | 18 Jan, 2019
Johnson & Johnson has announced the completion of the acquisition of Ci:z Holdings Co., Ltd. for a total purchase pr...Read more
-
AIVITA gets IND nod for Phase 1B melanoma trial
Japan | News | 0 Comment | 17 Jan, 2019
AIVITA Biomedical, Inc., a biotech company specializing in innovative stem cell applications, announced that the U.S. Fo...Read more
-
Daiichi Sankyo to lead open innovation research on cell therapy
Japan | News | 0 Comment | 11 Jan, 2019
Daiichi Sankyo Company, Limited, Mitsubishi UFJ Capital Co., Ltd. and Tokyo Institute of Technology have announced that ...Read more
-
Japan approves Amgen's osteoporosis drug
Japan | News | 0 Comment | 10 Jan, 2019
Amgen and UCB announced that the Japanese Ministry of Health, Labor and Welfare has granted a marketing authorizat...Read more
-
Daiichi Sankyo receives regulatory approval for hypertension tablets
Japan | News | 0 Comment | 10 Jan, 2019
Exelixis, Inc. has announced that its partner Daiichi Sankyo Company, Limited received approval from the Japanese Minist...Read more
-
NapaJen Pharma closes $12.4M Series C financing
Japan | News | 0 Comment | 09 Jan, 2019
NapaJen Pharma, Inc., a biotherapeutics company leveraging its proprietary immune cell-targeted oligonucleotide delivery...Read more
-
Takeda completes acquisition of Shire
Japan | News | 0 Comment | 08 Jan, 2019
Takeda Pharmaceutical Company Limited (“Takeda”) announced the completion of its acquisition of Shire plc (&...Read more
-
Fujifilm to invest 10B Yen in Bio CDMO biz
Japan | News | 0 Comment | 08 Jan, 2019
FUJIFILM Corporation announced plans to invest approximately JPY 10 billion (approximately $90 million U.S. dollars) in ...Read more
-
Solasia initiates Phase III programme for PledOx
Japan | News | 0 Comment | 07 Jan, 2019
Solasia Pharma K.K. has announced the initiation of Phase III clinical trial for PledOx in Japan. In November 2017, Sol...Read more
-
Otsuka, Click Therapeutics to create therapy for mental illness
Japan | News | 0 Comment | 07 Jan, 2019
Otsuka Pharmaceutical Co., Ltd. announces that its U.S. holding company subsidiary Otsuka America, Inc, and Click Therap...Read more
-
Takeda announces multiple cell therapy collaborations
Japan | News | 0 Comment | 04 Jan, 2019
Takeda Pharmaceutical has announced new research collaborations in immuno-oncology (I-O), an area of key strategic...Read more
-
Researchers discover laminin which can convert stem cells into retinal-like cells
Japan | News | 1 Comment | 02 Jan, 2019
Researchers from Osaka University in Japan have discovered a way to convert human pluripotent stem cells into various ce...Read more
-
MediPharm Labs declares its addition to HMMJ Index
Japan | News | 0 Comment | 31 Dec, 2018
MediPharm Labs Corp., a specialized, research-driven cannabis extraction business licensed under the Cannabis Act, is pl...Read more
-
Taisho Pharmaceutical Holdings to purchase BMS's UPSA
Japan | News | 0 Comment | 30 Dec, 2018
Bristol-Myers Squibb Company recently announced that Taisho Pharmaceutical Holdings has offered to purchase Bristol-Myer...Read more
-
Prevelance of colistin-resistance high in Vietnam: Research
Japan | News | 0 Comment | 28 Dec, 2018
A team of researchers led by Osaka University examined the dissemination of colistin-resistant bacteria among residents ...Read more
-
Chugai obtains approval for Genomic Mutation Analysis Program
Japan | News | 0 Comment | 27 Dec, 2018
Chugai Pharma has announced today that it has obtained regulatory approval from the Ministry of Health, Labour and Welfa...Read more
